Skip to main content
Top
Published in: Endocrine 1/2012

01-02-2012 | Original Article

Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study

Authors: Maryam S. Daneshpour, Bita Faam, Mohamad Ali Mansournia, Mehdi Hedayati, Sohrab Halalkhor, Seyed Alireza Mesbah-Namin, Shahla Shojaei, Maryam Zarkesh, Fereidoun Azizi

Published in: Endocrine | Issue 1/2012

Login to get access

Abstract

Iranian populations show an increased tendency for abnormal lipid levels and high risk of Coronary artery disease. Considering the important role played by the ApoAI-CIII-AIV gene cluster in the regulation of the level and metabolism of lipids, this study aimed at elucidating the association between five single nucleotide polymorphisms on the Apo11q cluster gene and lipid levels. A cross-sectional study of 823 subjects (340 males and 483 females) from the Tehran lipid and glucose study (TLGS) was conducted. Levels of TG, Chol, HDL-C, Apo AI, Apo AIV, Apo B, and Apo CIII were measured, and the selected segments of the APOAI-CIII-AIV gene cluster were amplified by PCR and the polymorphisms were revealed by RFLP using restriction enzymes. The allele frequencies for each SNP between males and females were not significantly different. The distribution of Genotypes and alleles was in Hardy–Weinberg equilibrium except for Apo AI (+83C>T). The results showed a significant association between TG, HDL-C, HDL2, Apo AI, and Apo B levels and the presence of some alleles in the polymorphisms studied. After haplotype analysis not only did the association between these variables and SNPs remain but also levels of Chol and LDL-C were added. This study demonstrates that the level of lipids such as TG, HDL-C, HDL2, Apo AI, and Apo B, maybe regulated partly by genetic factors and their haplotype within the Apo11q gene cluster.
Literature
1.
go back to reference L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, E.M. Rubin, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173 (2001)PubMedCrossRef L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, E.M. Rubin, An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173 (2001)PubMedCrossRef
2.
go back to reference Q.F. Wang, X. Liu, J. O’Connell, Z. Peng, R.M. Krauss, D.L. Rainwater, J.L. VandeBerg, E.M. Rubin, J.F. Cheng, L.A. Pennacchio, Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum. Mol. Genet. 13, 1049–1056 (2004)PubMedCrossRef Q.F. Wang, X. Liu, J. O’Connell, Z. Peng, R.M. Krauss, D.L. Rainwater, J.L. VandeBerg, E.M. Rubin, J.F. Cheng, L.A. Pennacchio, Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum. Mol. Genet. 13, 1049–1056 (2004)PubMedCrossRef
3.
go back to reference M. Olivier, X. Wang, R. Cole, B. Gau, J. Kim, E.M. Rubin, L.A. Pennacchio, Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83, 912–923 (2004)PubMedCrossRef M. Olivier, X. Wang, R. Cole, B. Gau, J. Kim, E.M. Rubin, L.A. Pennacchio, Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83, 912–923 (2004)PubMedCrossRef
4.
go back to reference J. Gao, Y. Wei, Y. Huang, D. Liu, G. Liu, M. Wu, L. Wu, Q. Zhang, Z. Zhang, R. Zhang, C. Liang, The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. J. Biol. Chem. 280, 12559–12566 (2005)PubMedCrossRef J. Gao, Y. Wei, Y. Huang, D. Liu, G. Liu, M. Wu, L. Wu, Q. Zhang, Z. Zhang, R. Zhang, C. Liang, The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. J. Biol. Chem. 280, 12559–12566 (2005)PubMedCrossRef
5.
go back to reference M. Daneshpour, M. Hedayati, P. Eshraghi, F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur. J. Lipid Sci. Technol. (2010 in press) M. Daneshpour, M. Hedayati, P. Eshraghi, F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur. J. Lipid Sci. Technol. (2010 in press)
6.
go back to reference S. Eichenbaum-Voline, M. Olivier, E.L. Jones, R.P. Naoumova, B. Jones, B. Gau, H.N. Patel, M. Seed, D.J. Betteridge, D.J. Galton, E.M. Rubin, J. Scott, C.C. Shoulders, L.A. Pennacchio, Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24, 167–174 (2004)PubMedCrossRef S. Eichenbaum-Voline, M. Olivier, E.L. Jones, R.P. Naoumova, B. Jones, B. Gau, H.N. Patel, M. Seed, D.J. Betteridge, D.J. Galton, E.M. Rubin, J. Scott, C.C. Shoulders, L.A. Pennacchio, Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24, 167–174 (2004)PubMedCrossRef
7.
go back to reference R. Mar, P. Pajukanta, H. Allayee, M. Groenendijk, G. Dallinga-Thie, R.M. Krauss, J.S. Sinsheimer, R.M. Cantor, T.W. de Bruin, A.J. Lusis, Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94, 993–999 (2004)PubMedCrossRef R. Mar, P. Pajukanta, H. Allayee, M. Groenendijk, G. Dallinga-Thie, R.M. Krauss, J.S. Sinsheimer, R.M. Cantor, T.W. de Bruin, A.J. Lusis, Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94, 993–999 (2004)PubMedCrossRef
8.
go back to reference M. Groenendijk, R.M. Cantor, T.W. de Bruin, G.M. Dallinga-Thie, The apoAI-CIII-AIV gene cluster. Atherosclerosis 157, 1–11 (2001)PubMedCrossRef M. Groenendijk, R.M. Cantor, T.W. de Bruin, G.M. Dallinga-Thie, The apoAI-CIII-AIV gene cluster. Atherosclerosis 157, 1–11 (2001)PubMedCrossRef
9.
go back to reference D.M. Hallman, S.R. Srinivasan, W. Chen, E. Boerwinkle, G.S. Berenson, Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa heart study. Metabolism 55, 1574–1581 (2006)PubMedCrossRef D.M. Hallman, S.R. Srinivasan, W. Chen, E. Boerwinkle, G.S. Berenson, Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa heart study. Metabolism 55, 1574–1581 (2006)PubMedCrossRef
10.
go back to reference M.C. Huang, T.N. Wang, Y.L. Liu, T.H. Pa, H.P. Tu, Y.C. Huang, W.T. Chang, Y.C. Ko, Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines. Circ. J. 70, 1030–1036 (2006)PubMedCrossRef M.C. Huang, T.N. Wang, Y.L. Liu, T.H. Pa, H.P. Tu, Y.C. Huang, W.T. Chang, Y.C. Ko, Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines. Circ. J. 70, 1030–1036 (2006)PubMedCrossRef
11.
go back to reference J. Song, J.W. Park, H. Park, J.Q. Kim, Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans. Mol. Cells 8, 12–18 (1998)PubMed J. Song, J.W. Park, H. Park, J.Q. Kim, Linkage disequilibrium of the Apo AI-CIII-AIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans. Mol. Cells 8, 12–18 (1998)PubMed
12.
go back to reference M.S. Daneshpour, M. Hedayati, P. Eshraghi, M. Hooshmand, F. Azizi, Asociation of apolipoprotein E gene polymorphism and lipid level in an Iranian population: Tehran Lipid and Glucose study. Iran. J. Diabet. Lipid 7, 399–405 (2008) M.S. Daneshpour, M. Hedayati, P. Eshraghi, M. Hooshmand, F. Azizi, Asociation of apolipoprotein E gene polymorphism and lipid level in an Iranian population: Tehran Lipid and Glucose study. Iran. J. Diabet. Lipid 7, 399–405 (2008)
13.
go back to reference M.S. Daneshpour, M. Hedayati, F. Azizi, Association of the TaqI and −629C>A polymorphisms in CETP gene with low level of HDL-C in Tehran. Pajouhesh Q. Res. J. 29, 13–17 (2005) M.S. Daneshpour, M. Hedayati, F. Azizi, Association of the TaqI and −629C>A polymorphisms in CETP gene with low level of HDL-C in Tehran. Pajouhesh Q. Res. J. 29, 13–17 (2005)
14.
go back to reference F. Azizi, M. Rahmani, H. Emami, P. Mirmiran, R. Hajipour, M. Madjid, J. Ghanbili, A. Ghanbarian, Y. Mehrabi, N. Saadat, P. Salehi, N. Mortazavi, P. Heydarian, N. Sarbazi, S. Allahverdian, N. Saadati, E. Ainy, S. Moeini, Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 47, 408–426 (2002)PubMedCrossRef F. Azizi, M. Rahmani, H. Emami, P. Mirmiran, R. Hajipour, M. Madjid, J. Ghanbili, A. Ghanbarian, Y. Mehrabi, N. Saadat, P. Salehi, N. Mortazavi, P. Heydarian, N. Sarbazi, S. Allahverdian, N. Saadati, E. Ainy, S. Moeini, Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz. Praventivmed. 47, 408–426 (2002)PubMedCrossRef
15.
go back to reference F. Azizi, M. Rahmani, H. Emami, M. Madjid, Tehran lipid and glucose study: rationale and design. CVD Prev. 3, 242–247 (2000) F. Azizi, M. Rahmani, H. Emami, M. Madjid, Tehran lipid and glucose study: rationale and design. CVD Prev. 3, 242–247 (2000)
16.
go back to reference F. Azizi, H. Emami, P. Salehi, A. Ghanbarian, P. Mirmiran, M. Mirbolooki, T. Azizi, Cardiovascular risk factors in the elderly: the Tehran lipid and glucose study. J. Cardiovasc. Risk 10, 65–73 (2003)PubMedCrossRef F. Azizi, H. Emami, P. Salehi, A. Ghanbarian, P. Mirmiran, M. Mirbolooki, T. Azizi, Cardiovascular risk factors in the elderly: the Tehran lipid and glucose study. J. Cardiovasc. Risk 10, 65–73 (2003)PubMedCrossRef
17.
go back to reference M. Daneshpour, M. Hedayati, P. Eshraghi, and F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur J. Lipid Sci. Technol. (2010) M. Daneshpour, M. Hedayati, P. Eshraghi, and F. Azizi, Association of Apo E gene polymorphism with HDL level in a Thehranian population. Eur J. Lipid Sci. Technol. (2010)
18.
go back to reference W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)PubMed
19.
go back to reference G.E. Truett, P. Heeger, R.L. Mynatt, A.A. Truett, J.A. Walker, M.L. Warman, Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29, 52–54 (2000)PubMed G.E. Truett, P. Heeger, R.L. Mynatt, A.A. Truett, J.A. Walker, M.L. Warman, Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29, 52–54 (2000)PubMed
20.
go back to reference Y. Zou, D. Hu, X. Yang, X. Jia, L. Wang, L. Cui, X. Liu, M. Gao, Y. Wei, Z. Xu, Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Chin. Med. J. (Engl) 116, 665–668 (2003) Y. Zou, D. Hu, X. Yang, X. Jia, L. Wang, L. Cui, X. Liu, M. Gao, Y. Wei, Z. Xu, Relationships among apolipoprotein A1 gene polymorphisms, lipid levels and coronary atherosclerosis disease. Chin. Med. J. (Engl) 116, 665–668 (2003)
21.
go back to reference J. Salas, S. Jansen, J. Lopez-Miranda, J.M. Ordovas, P. Castro, C. Marin, M.A. Ostos, M.D. Bravo, J. Jimenez-Pereperez, A. Blanco, F. Lopez-Segura, F. Perez-Jimenez, The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am. J. Clin. Nutr. 68, 396–401 (1998)PubMed J. Salas, S. Jansen, J. Lopez-Miranda, J.M. Ordovas, P. Castro, C. Marin, M.A. Ostos, M.D. Bravo, J. Jimenez-Pereperez, A. Blanco, F. Lopez-Segura, F. Perez-Jimenez, The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am. J. Clin. Nutr. 68, 396–401 (1998)PubMed
22.
go back to reference T.F. Ejchel, L.M. Araujo, L.R. Ramos, M.S. Cendoroglo, M. de Arruda Cardoso Smith, Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population. Am. J. Med. Genet. B 135B, 65–68 (2005)CrossRef T.F. Ejchel, L.M. Araujo, L.R. Ramos, M.S. Cendoroglo, M. de Arruda Cardoso Smith, Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population. Am. J. Med. Genet. B 135B, 65–68 (2005)CrossRef
23.
go back to reference S. Tas, Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin. Chem. 35, 256–259 (1989)PubMed S. Tas, Strong association of a single nucleotide substitution in the 3′-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin. Chem. 35, 256–259 (1989)PubMed
24.
go back to reference E.J. Topol, J. Smith, E.F. Plow, Q.K. Wang, Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15(Spec No 2), 117–123 (2006)CrossRef E.J. Topol, J. Smith, E.F. Plow, Q.K. Wang, Genetic susceptibility to myocardial infarction and coronary artery disease. Hum. Mol. Genet. 15(Spec No 2), 117–123 (2006)CrossRef
25.
go back to reference R. Bahri, E. Esteban, P. Moral, M. Hassine, K. Ben Hamda, H. Chaabani, Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis. 7, 46 (2008)PubMedCrossRef R. Bahri, E. Esteban, P. Moral, M. Hassine, K. Ben Hamda, H. Chaabani, Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis. 7, 46 (2008)PubMedCrossRef
26.
go back to reference S.Y. Hung, H.H. Liou, L.P. Ger, L.K. Chen, M.C. Liu, H.M. Chung, K.J. Chou, T.H. Chen, C.K. Lin, Y. Yang, Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients. Am. J. Nephrol. 30, 222–231 (2009)PubMedCrossRef S.Y. Hung, H.H. Liou, L.P. Ger, L.K. Chen, M.C. Liu, H.M. Chung, K.J. Chou, T.H. Chen, C.K. Lin, Y. Yang, Clustering of unconventional cardiovascular risk factors among Taiwanese hemodialysis patients. Am. J. Nephrol. 30, 222–231 (2009)PubMedCrossRef
27.
go back to reference T. Nieminen, M. Kahonen, S. Islam, O.T. Raitakari, N. Hutri-Kahonen, J. Marniemi, M. Juonala, R. Rontu, J. Viikari, T. Lehtimaki, Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the cardiovascular risk in young Finns study. Circ. J. 71, 741–745 (2007)PubMedCrossRef T. Nieminen, M. Kahonen, S. Islam, O.T. Raitakari, N. Hutri-Kahonen, J. Marniemi, M. Juonala, R. Rontu, J. Viikari, T. Lehtimaki, Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the cardiovascular risk in young Finns study. Circ. J. 71, 741–745 (2007)PubMedCrossRef
28.
go back to reference P.J. Talmud, E. Hawe, S. Martin, M. Olivier, G.J. Miller, E.M. Rubin, L.A. Pennacchio, S.E. Humphries, Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039–3046 (2002)PubMedCrossRef P.J. Talmud, E. Hawe, S. Martin, M. Olivier, G.J. Miller, E.M. Rubin, L.A. Pennacchio, S.E. Humphries, Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum. Mol. Genet. 11, 3039–3046 (2002)PubMedCrossRef
29.
go back to reference S.H. Hong, W.H. Park, C.C. Lee, J.H. Song, J.Q. Kim, Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin. Chem. 43, 13–17 (1997)PubMed S.H. Hong, W.H. Park, C.C. Lee, J.H. Song, J.Q. Kim, Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin. Chem. 43, 13–17 (1997)PubMed
30.
go back to reference J. Shanker, G. Perumal, V.S. Rao, N.B. Khadrinarasimhiah, S. John, S. Hebbagodi, M. Mukherjee, V.V. Kakkar, Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis. 7, 33 (2008)PubMedCrossRef J. Shanker, G. Perumal, V.S. Rao, N.B. Khadrinarasimhiah, S. John, S. Hebbagodi, M. Mukherjee, V.V. Kakkar, Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis. 7, 33 (2008)PubMedCrossRef
Metadata
Title
Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran lipid and glucose study
Authors
Maryam S. Daneshpour
Bita Faam
Mohamad Ali Mansournia
Mehdi Hedayati
Sohrab Halalkhor
Seyed Alireza Mesbah-Namin
Shahla Shojaei
Maryam Zarkesh
Fereidoun Azizi
Publication date
01-02-2012
Publisher
Springer US
Published in
Endocrine / Issue 1/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9526-6

Other articles of this Issue 1/2012

Endocrine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.